SCMP Financial Facts

Selling and marketing: 592K
Comprehensive income (loss): 9.25M
See Full Income Statement

Common stock: 451K
Total assets: 160.26M
See Full Balance Sheet

Sucampo Pharmaceuticals (SCMP) Earnings

  |   Expand Research on SCMP
Next EPS Date 11/5/15 *Est. EPS Growth Rate N/A
Average EPS % Beat Rate +12.1% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +11.9% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/5/15 Q215 $0.21$0.15 +$0.06$34.9M$31.9M = Details
5/6/15 Q115 $0.14$0.12 +$0.02$29.5M$30.19M = Details
3/4/15 Q413 $0.21$0.18 +$0.03$37.8M$37.23M = Details
11/6/14 Q313 $0.03$0.04 -$0.01$31.5M$26.11M N/A Details
8/5/14 Q213 $0.04$0.03 +$0.01$24.1M$24.06M N/A Details
5/7/14 Q113 $0.02$0.04 -$0.02$22.2M$24.19M N/A Details
3/13/13 Q412 $0.32$0.12 +$0.20$34.9M$32.21M N/A Details
3/13/12 Q411 $0.06N/A N/A $14.22M$15.9M N/A Details